Jane E. Churpek, MD, describes the BROCA genetic assay, uses targeted genomic capture and next-generation sequencing to analyze a panel of 42 genes.
Jane E. Churpek, MD, medical oncologist, hematologist, The University of Chicago, describes the BROCA genetic assay.
The BROCA assay uses new tools called targeted genomic capture and next-generation sequencing to analyze a panel of 42 genes. Of those 42 genes, 18 are breast cancer susceptibility genes, including BRCA 1 and BRCA 2.
Successes With T-DXd and the Need for Continued Research in Brain Metastasis
June 13th 2024In an interview with Targeted Oncology, Sarah Sammons, MD, discussed an analysis of the DESTINY-Breast03 trial, highlighting the need for further research on trastuzumab deruxtecan in other breast cancer subtypes and solid tumors with brain metastases.
Read More